Akèy › Obèsite › Texas › Amarillo
Etid klinik pou Obèsite nan Amarillo, TX
10 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Amarillo (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 2
- Amarillo Medical Specialists /ID# 282380, Amarillo
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Ap rekriteFaz 3
- Amarillo Medical Specialists, Amarillo
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Ap rekriteFaz 3
- Amarillo Med Spec LLP, Amarillo
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Ap rekriteFaz 3
- Amarillo Medical Specialists, Amarillo
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- PharmaTex Research, LLC, Amarillo
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Ap rekriteFaz 3
- PharmaTex Research, LLC, Amarillo
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Amarillo
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Amarillo
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Ap rekriteFaz 3
- PharmaTex Research, LLC, Amarillo
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Ap rekriteFaz 1
- Amarillo Medical Specialists, Amarillo
Etid Obèsite nan lòt vil
- Houston, TX44 etid
- Chicago, IL42 etid
- New York City, NY40 etid
- San Antonio, TX39 etid
- Washington, DC33 etid
- Dallas, TX31 etid
- Orlando, FL29 etid
- Boston, MA28 etid
- Miami, FL27 etid
- Las Vegas, NV27 etid
- Atlanta, GA25 etid
- Jacksonville, FL25 etid
Lòt etid nan Amarillo
- Kansè Poumon ki pa ti selil8 etid
- Ensifizyans kadyak8 etid
- Sipwa7 etid
- Ateroskleroz6 etid
- Maladi kadyovaskilè5 etid
- Kansè poumon5 etid
- Kayò san4 etid
- Kansè nan tete3 etid
- Fibrilasyon atriyal3 etid
- Maladi Dijestif3 etid
- Kansè kolorektal3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.